Nano-Biomimetic Drug Delivery Vehicles: Potential Approaches for COVID-19 Treatment

The current COVID-19 pandemic has tested the resolve of the global community with more than 35 million infections worldwide and numbers increasing with no cure or vaccine available to date. Nanomedicines have an advantage of providing enhanced permeability and retention and have been extensively stu...

Descrición completa

Detalles Bibliográficos

Principais autores:	Bwalya A. Witika, Pedzisai A. Makoni, Larry L. Mweetwa, Pascal V. Ntemi, Melissa T. R. Chikukwa, Scott K. Matafwali, Chiluba Mwila, Steward Mudenda, Jonathan Katandula, Roderick B. Walker
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2020-12-01
Series:	Molecules
Assuntos:	biomimetic drug delivery SARS-CoV-2 COVID-19 nanotechnology cytokine storm syndrome nanomedicine
Acceso en liña:	https://www.mdpi.com/1420-3049/25/24/5952
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!